Major triple yang generally refers to hepatitis B major triple yang, and hepatitis B major triple yang virus carriers generally do not need to be treated. Hepatitis B triple positive refers to the immunity index of hepatitis B virus in patients with chronic hepatitis B or hepatitis B virus carriers, i.e., hepatitis B surface antigen, hepatitis B e antigen and hepatitis B core antibody are positive. Hepatitis B virus carriers usually have no symptoms, and if their liver function is normal, liver ultrasound is normal, and their growth indicators and even pathological indicators are normal, they do not need to be treated. Hepatitis B triple positive carriers although liver function is normal, but the body still exists in the replication of the virus, highly contagious, is likely to further develop into hepatitis B triple positive patients. Hepatitis B triple positive carriers with cirrhosis, or even liver cancer, or with a family history of liver cancer, and older than 30 years of age, are also recommended to take oral antiviral drugs (such as entecavir, etc.) for treatment, in order to reduce the risk of liver cancer. Hepatitis B teratitis carriers should not ignore their condition, and should go to the hospital regularly for a comprehensive examination to observe the development of their condition. Moreover, they should control the intake of fat and stop drinking alcohol in order to minimize the damage to the liver.